Svensson, T., Chowdhury, O., Garelius, H., Lorenz, F., Saft, L., Jacobsen, S., . . . Cherif, H. (2014). A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
Цитирование в стиле Чикаго (17-е изд.)Svensson, T., O. Chowdhury, H. Garelius, F. Lorenz, L. Saft, SE Jacobsen, E. Hellström-Lindberg, и H. Cherif. A Pilot Phase I Dose Finding Safety Study of the Thrombopoietin-receptor Agonist, Eltrombopag, in Patients with Myelodysplastic Syndrome Treated with Azacitidine. 2014.
Цитирование MLA (9-е изд.)Svensson, T., et al. A Pilot Phase I Dose Finding Safety Study of the Thrombopoietin-receptor Agonist, Eltrombopag, in Patients with Myelodysplastic Syndrome Treated with Azacitidine. 2014.